Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nuvectis Pharma, Inc. - Common Stock (NQ: NVCT )

12.35 -0.01 (-0.08%)
Streaming Delayed Price Updated: 3:47 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,828
Open 12.14
Bid (Size) 11.83 (1)
Ask (Size) 12.35 (2)
Prev. Close 12.36
Today's Range 11.50 - 12.35
52wk Range 6.020 - 20.92
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Nuvectis Pharma Announces Upcoming Presentations at the 2023 American Association for Cancer Research Meeting
From Nuvectis Pharma, Inc.
Via Globe NewsWire
Nuvectis Pharma to Participate in a Fireside Chat at the 35th Annual Roth Conference
From Nuvectis Pharma, Inc.
Via Globe NewsWire

Performance

YTD
+64.67%
+64.67%
1 Month
+22.28%
+22.28%
3 Month
+68.72%
+68.72%
6 Month
+56.53%
+56.53%
1 Year
+104.81%
+104.81%

More News

Read More
Nuvectis Pharma Recaps Poster Presentation Highlights for NXP800 at the 2023 ESMO Gynecological Cancers Congress
From Nuvectis Pharma, Inc.
Via Globe NewsWire
Nuvectis Pharma Announces Collaboration with ENGOT and GOG Foundation to Conduct the NXP800 Phase 1b Clinical Trial in ARID1A-Mutated Ovarian Carcinoma in Europe and in the United States
From Nuvectis Pharma, Inc.
Via Globe NewsWire
FDA Grants Fast Track Designation to Nuvectis Pharma's NXP800 for the Treatment of Platinum-Resistant, ARID1A-Mutated Ovarian Carcinoma
From Nuvectis Pharma, Inc.
Via Globe NewsWire
Nuvectis Pharma, Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
From Nuvectis Pharma, Inc.
Via Globe NewsWire
Nuvectis Pharma Announces Formation of a Scientific Advisory Board
From Nuvectis Pharma, Inc.
Via Globe NewsWire
Nuvectis Pharma, Inc. Announces Approximately $15.9 Million Private Placement
From Nuvectis Pharma, Inc.
Via Globe NewsWire
5 Best Performing Micro-Cap Stocks Through the First Half of 2022
Via Spotlight Growth
Topics Stocks
Exposures Fossil Fuels US Equities
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
Via Benzinga
Nuvectis Pharma Gets FDA Nod For Initial-Stage Ovarian Cancer Study
Via Benzinga
82 Biggest Movers From Yesterday
Via Benzinga
92 Biggest Movers From Friday
Via Benzinga
83 Biggest Movers From Yesterday
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
51 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Opening Day: AN2 Therapeutics Rises In Public Debut After Upsized IPO
Via Talk Markets
68 Biggest Movers From Yesterday
Via Benzinga
75 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.